RAPT vs TJX · $132.1M cap vs P/E 32, rev $29.50B
RAPT Therapeutics Inc (RAPT) versus The TJX Companies Inc (TJX) — a side-by-side from cached financials, not a winner call.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
The TJX Companies Inc (TJX) is a apparel retail company listed on NYSE. It is led by Ernie L. Herrman.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
Latest reported TJX revenue for 2026-08-01 was $29.50B. Net income was $2.85B. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
RAPT currently screens at market cap $132.1M. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
Not investment advice. Open the RAPT and TJX stock pages for the full models.
Not investment advice.